Skip to content

Atys

FranceFDA 510(k) applicant, unverified

Devices
1

What Atys makes

Atys manufactures the TCD-X, a transcranial Doppler ultrasound device used for assessing cerebral blood flow and detecting conditions such as vasospasm or embolism in neurocritical care settings.

The TCD-X is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) clearance pathway. The company is based in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Tcd-X Ref K182175

    Class II
    Active 510(k) 510(k) II

Frequently asked questions

How many devices does Atys have in the registry?

The registry currently lists 1 device for Atys. Devices recorded under merged duplicate company entries are counted once.

Which registries list Atys's devices?

Among its 1 most recently registered device, Atys has devices listed in FDA 510(k) (1 device).

What risk classes do Atys's devices fall under?

Among its 1 most recently registered device, the classes recorded for Atys's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Atys in the registry?

The most recently registered devices listed for Atys include TCD-X.

Generated automatically from registry data and not verified by a human reviewer.